Selected Publications

Academic Article

Year Title Altmetric
2023 Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patientsFrontiers in Cardiovascular Medicine.  9. 2023
2022 Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registryEuropean Journal of Cancer.  177:197-205. 2022
2022 Current Practice in Carcinoid Heart Disease and Burgeoning OpportunitiesCurrent Treatment Options in Oncology.  23:1793-1803. 2022
2022 Innovations in Cardio-oncology Resulting from the COVID-19 PandemicCurrent Treatment Options in Oncology.  23:1288-1302. 2022
2022 Racial and rural–urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort 2022
2021 Cardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC cardio-oncology and imaging councils 2021
2020 By Releasing the Brakes with Immunotherapy, Are We Accelerating Atherosclerosis?Circulation.  142:2312-2315. 2020
2020 Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imagingAmerican Heart Journal.  226:127-139. 2020
2020 Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors 2020
2020 Strategies to Prevent CardiotoxicityCurrent Treatment Options in Oncology.  21. 2020
2019 Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council PerspectivesJournal of the American College of Cardiology.  74:3153-3163. 2019
2019 Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the WeekJournal of the American College of Cardiology.  73:2226-2235. 2019
2018 Effects of endogenous serum neuregulin-1β on morbidity and mortality in patients with heart failure and left ventricular systolic dysfunctionBiomarkers.  23:704-708. 2018
2018 Bortezomib-induced cardiac tamponade in a 49-year-old manTexas Heart Institute Journal.  45:260-263. 2018
2018 Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialAmerican Heart Journal.  201:54-62. 2018
2017 ERBB signaling attenuates proinflammatory activation of nonclassical monocytes 2017
2016 Echocardiographic Assessment of Cardiotoxic Effects of Cancer TherapyCurrent Cardiology Reports.  18. 2016
2016 Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary SpecialtyJournal of Cardiac Failure.  22:465-471. 2016
2016 Cardio-oncology: An update on cardiotoxicity of cancer-related treatmentCirculation Research.  118:1008-1020. 2016
2016 Getting the SCOOP—Survey of Cardiovascular Outcomes From Oncology Patients During SurvivorshipAmerican Journal of the Medical Sciences.  351:570-575. 2016
2014 Sympathetic nervous system alterations with HER2+ antagonism: An early marker of cardiac dysfunction with breast cancer treatment?ecancermedicalscience.  8. 2014
2014 Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failureCurrent Heart Failure Reports.  11:134-138. 2014
2013 Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertensionPulmonary Circulation.  3:345-349. 2013
2013 Intravenous Glial Growth Factor 2 (GGF2) Isoform of Neuregulin-1β Improves Left Ventricular Function, Gene and Protein Expression in Rats after Myocardial InfarctionPLoS One.  8. 2013
2013 Heart transplant survival outcomes for adriamycin-dilated cardiomyopathyAmerican Journal of Cardiology.  111:609-612. 2013


Year Title Altmetric
2017 Epidemiology of cardio-oncology.  1-14. 2017
2015 Congestive heart failure: Differential diagnosis 2015

Education And Training

  • Vanderbilt University, Residency
  • Vanderbilt University, Postdoctoral Fellowship
  • Master of Science in Clinical Research Coordinator, Vanderbilt University 2010
  • Doctor of Medicine, Medical University of South Carolina 2003
  • Full Name

  • Carrie Lenneman